T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Tenaya Therapeutics
TNYA
$164M
| $11.4M | ﹤0.01% |
4,475,166
+5,525
| +0.1% | +$23.1K |
|
1052
Universal Health Services
UHS
$10.1B
| $11.4M | ﹤0.01% |
90,418
-2,808
| -3% | -$383K |
|
1053
Twist Bioscience
TWST
$7.86B
| $11.3M | ﹤0.01% |
559,957
-21,683
| -4% | -$476K |
|
1054
Valmont Industries
VMI
$9.5B
| $11.3M | ﹤0.01% |
47,112
-47,144
| -50% | -$12.1M |
|
1055
Voya Financial
VOYA
$9.16B
| $11.3M | ﹤0.01% |
169,973
-1,610
| -0.9% | -$115K |
|
1056
Ollie's Bargain Outlet
OLLI
$4.7B
| $11.2M | ﹤0.01% |
145,320
-5,315
| -4% | -$388K |
|
1057
Markel Group
MKL
$22.8B
| $11.2M | ﹤0.01% |
7,604
-141
| -2% | -$206K |
|
1058
Robert Half
RHI
$4.48B
| $11.2M | ﹤0.01% |
152,450
-9,918
| -6% | -$752K |
|
1059
iShares MSCI India ETF
INDA
$6.58B
| $11.1M | ﹤0.01% |
251,210
-4,500
| -2% | -$199K |
|
1060
American Airlines Group
AAL
$9.97B
| $11.1M | ﹤0.01% |
863,128
+1,693
| +0.2% | +$26.3K |
|
1061
EyePoint Inc
EYPT
$1.16B
| $11M | ﹤0.01% |
+1,374,346
| New | +$15.1M |
|
1062
Carlisle Companies
CSL
$14.9B
| $10.9M | ﹤0.01% |
41,946
+501
| +1% | +$134K |
|
|
HCP
1063
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $10.7M | ﹤0.01% |
469,736
-1,215,741
| -72% | -$33M |
|
1064
United Parks & Resorts
PRKS
$2.04B
| $10.7M | ﹤0.01% |
231,384
-117,968
| -34% | -$6M |
|
1065
Campbell Soup
CPB
$6.94B
| $10.5M | ﹤0.01% |
256,121
-15,188
| -6% | -$664K |
|
1066
Fox Class A
FOXA
$27.5B
| $10.4M | ﹤0.01% |
332,975
-28,402
| -8% | -$933K |
|
1067
Vale
VALE
$58.7B
| $10.2M | ﹤0.01% |
760,640
+82,100
| +12% | +$1.12M |
|
1068
SolarEdge
SEDG
$1.98B
| $10.2M | ﹤0.01% |
78,444
-427,394
| -84% | -$82M |
|
1069
GitLab
GTLB
$7.32B
| $10.1M | ﹤0.01% |
222,466
-260,303
| -54% | -$12.5M |
|
1070
Vail Resorts
MTN
$5.18B
| $10M | ﹤0.01% |
45,166
-101,923
| -69% | -$24.2M |
|
|
HSAI
1071
Hesai Group
HSAI
$3.03B
| $9.86M | ﹤0.01% |
986,108
-17,264
| -2% | -$188K |
|
|
LBPH
1072
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $9.86M | ﹤0.01% |
1,772,348
+81,018
| +5% | +$522K |
|
1073
Lyell Immunopharma
LYEL
$337M
| $9.83M | ﹤0.01% |
334,310
-73,745
| -18% | -$3.5M |
|
1074
Whirlpool
WHR
$2.79B
| $9.76M | ﹤0.01% |
72,955
+248
| +0.3% | +$35K |
|
1075
Green Brick Partners
GRBK
$3.04B
| $9.66M | ﹤0.01% |
232,799
+224,660
| +2,760% | +$11.2M |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.